Akanda Corp (AKAN) AI Stock Analysis

266 Followers

Akanda Corp

(NASDAQ:AKAN)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

Akanda Corp (AKAN) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $3.25M
Dividend Yield: ―
Average Volume (3M): 2.27M
Price to Earnings (P/E): -0.0
Beta (1Y): 3.36
Revenue Growth: 84.19%
EPS Growth: -8.94%
Country: US
Employees: 8
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Akanda Corp Business Overview & Revenue Model

Company Description

Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim t...

Akanda Corp Risk Analysis

Akanda Corp disclosed 54 risk factors in its most recent earnings report. Akanda Corp reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk

1.Our executive officers are engaged in other business activities and, accordingly, may not devote sufficient time to our business affairs, which may affect our ability to conduct operations.Q4, 2023

Akanda Corp Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

AKAN against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SNDL	55Neutral	$338.22M	-7.74	-5.50%	―	-2.49%	32.03%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TLRY	46Neutral	$367.99M	-1.74	-10.30%	―	15.93%	93.85%
IXHL	43Neutral	$25.34M	-2.94	-12.40%	―	-100.00%	96.25%
IMCC	37Underperform	$911.06K	-0.02	841.81%	―	-11.91%	-285.26%

* Healthcare Sector Average

Performance Comparison

AKAN and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
AKAN	Akanda Corp	1.36	-22.04	-94.19%
TLRY	Tilray	2.43	-7.87	-76.41%
SNDL	Sndl Inc.	1.37	-0.30	-17.96%
IMCC	Im Cannabis Corp	0.57	-29.39	-98.10%
IXHL	Incannex Healthcare Limited Sponsored ADR	1.97	-8.21	-80.65%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Akanda Corp AI Stock Analysis